Author
Listed:
- Haoxing Zhang
(School of Life Sciences, Southwest University)
- Hailong Liu
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine)
- Yali Chen
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine)
- Xu Yang
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine)
- Panfei Wang
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine)
- Tongzheng Liu
(Mayo Clinic, Rochester)
- Min Deng
(Mayo Clinic, Rochester)
- Bo Qin
(Mayo Clinic, Rochester)
- Cristina Correia
(Mayo Clinic, Rochester)
- Seungbaek Lee
(Mayo Clinic, Rochester)
- Jungjin Kim
(Mayo Clinic, Rochester)
- Melanie Sparks
(Washington University)
- Asha A. Nair
(BSI-Genetics & Bioinformatics, Mayo Clinic)
- Debra L. Evans
(Mayo Clinic, Rochester)
- Krishna R. Kalari
(BSI-Genetics & Bioinformatics, Mayo Clinic)
- Pumin Zhang
(Baylor College of Medicine)
- Liewei Wang
(Molecular Pharmacology and Experimental therapeutics, Mayo Clinic)
- Zhongsheng You
(Washington University)
- Scott H. Kaufmann
(Mayo Clinic, Rochester)
- Zhenkun Lou
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine
Mayo Clinic, Rochester
Molecular Pharmacology and Experimental therapeutics, Mayo Clinic)
- Huadong Pei
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine)
Abstract
BRCA1 is an important mediator of the DNA damage response, which promotes homologous recombination (HR) and antagonizes 53BP1-dependent non-homologous end joining in S/G2 phase. But how this is achieved remains unclear. Here, we report that the E3 ubiquitin ligase UHRF1 (Ubiquitin-like, with PHD and RING finger domains 1) directly participates in the interplay between BRCA1 and 53BP1. Mechanistically, UHRF1 is recruited to DNA double-strand breaks (DSBs) by BRCA1 in S phase, which requires the BRCT domain of BRCA1 and phosphorylated Ser674 of UHRF1. Subsequently, UHRF1 mediates K63-linked polyubiquitination of RIF1, and results in its dissociation from 53BP1 and DSBs thereby facilitating HR initiation. Thus, UHRF1 is a key regulator of DSB repair choice, which is separate from its role in heterochromatin formation and epigenetic regulator.
Suggested Citation
Haoxing Zhang & Hailong Liu & Yali Chen & Xu Yang & Panfei Wang & Tongzheng Liu & Min Deng & Bo Qin & Cristina Correia & Seungbaek Lee & Jungjin Kim & Melanie Sparks & Asha A. Nair & Debra L. Evans & , 2016.
"A cell cycle-dependent BRCA1–UHRF1 cascade regulates DNA double-strand break repair pathway choice,"
Nature Communications, Nature, vol. 7(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10201
DOI: 10.1038/ncomms10201
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Lianmei Tan & Tao Yin & Handan Xiang & Liuyang Wang & Poorva Mudgal & Junying Chen & Yi Ding & Guoping Wang & Bryan Jian Wei Lim & Yuqi Huang & De Huang & Yaosi Liang & Peter B. Alexander & Kun Xiang , 2024.
"Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response,"
Nature Communications, Nature, vol. 15(1), pages 1-15, December.
- Kaja Kostyrko & Marta Román & Alex G. Lee & David R. Simpson & Phuong T. Dinh & Stanley G. Leung & Kieren D. Marini & Marcus R. Kelly & Joshua Broyde & Andrea Califano & Peter K. Jackson & E. Alejandr, 2023.
"UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma,"
Nature Communications, Nature, vol. 14(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10201. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.